References
- . Barnhill JG, Fye CL, Williams DW, . Chondroitin product selection for the glucosamine/chondroitin arthritis intervention trial. J Am Pharm Assoc (2003). 2006;46(1):14–24
- . Clegg DO, Reda DJ, Harris CL, . Glucosamine, chondroitin sulfate and the two in combination for painful knee osteoarthritis. N Eng J Med. 2006;354(8):795–808
- . Ronca F, Palmieri L, Panicucci P, . Anti-inflammatory activity of chondroitin sulfate. Osteoarthritis Cartilage. 1998;6( suppl A):14–21
- . Kahan A, Uebelhart D, De Vathaire F, Delmas PD, Reginster JY. Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis. Arthritis Rheum. 2009;60(2):524–533
- . Herrero-Beaumont G, Ivorra JA, Del Carmen Trabado M, . Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator. Arthritis Rheum. 2007;56(2):555–567
- . Das AK, Hammad TA. Efficacy of a combination of FCHG49® glucosamine hydrochloride, TRH122® low molecular weight sodium chondroitin sulfate and manganese ascorbate in the management of knee osteoarthritis. Osteoarthritis Cartilage. 2000;8(5):343–350
- . Leffler CT, Philippi AF, Leffler SG, Mosure JC, Kim PD. Glucosamine, chondroitin and manganese ascorbate for degenerative joint disease of the knee or low back: a randomized, double-blind, placebo-controlled pilot study. Mil Med. 1999;164:85–91